Literature DB >> 21359545

Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?

Matthias Haas1, Maike Büttner, Tilman T Rau, Rainer Fietkau, Gerhard G Grabenbauer, Luitpold V Distel.   

Abstract

Tumor-infiltrating lymphocytes (TILs) in gastric adenocarcinoma show a strong compartmentalization with high numbers of lymphocytes in the stroma and low intraepithelial lymphocyte counts. Our previous study has shown stromal regulatory T cells (Treg) to be associated with a beneficial outcome in intestinal type cancer of the cardia. We undertook the present study to further evaluate the immunogenic and inflammatory environment in intestinal-type gastric adenocarcinoma of the cardia. We assessed CXCR3 expression, Epstein-Barr virus (EBV) status, Her2/ERBB2 status and overexpression/amplification using tissue microarrays (immunohistochemistry and in situ hybridization) of 52 patients. The data were correlated to different TIL subset counts (CD3, CD8, GranzymeB, FoxP3 and CD20) and to infiltrating histiocytes (CD68) both in the tumor and the surrounding stromal tissue that were reported earlier. Her2/ERBB2 overexpression/amplification showed no correlation to tumor stage. Moreover, for the first time, we show here that Her2/ERBB2 overexpression/amplification has no correlation to overall or subset-specific TIL infiltration. EBV infection was seen in four cases and showed a strong association with intratumoral CD8(+) T cell infiltration as well as a moderate correlation to stromal CD8(+) T cell accumulation. Intratumoral CD8(+) T cell infiltration was significantly correlated to intratumoral FoxP3(+) Treg infiltration, and to a lesser extent, to stromal FoxP3(+) Treg counts. Stromal CXCR3(+) T cell infiltration showed an inverse correlation to T category. This highlights the importance of stromal immune processes for cancer growth and suggests a subversion of Th1 immunoresponse in cancer progression and underlines the important role of inflammation for early carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359545     DOI: 10.1007/s00428-011-1058-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  40 in total

1.  Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus.

Authors:  Y Tajima; Y Nakanishi; T Yoshino; A Kokawa; M Kusano; T Shimoda
Journal:  Oncology       Date:  2001       Impact factor: 2.935

2.  Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.

Authors:  Satoshi Ohno; Mitsuo Tachibana; Toshiyuki Fujii; Shuhei Ueda; Hirofumi Kubota; Naofumi Nagasue
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

3.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

4.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.

Authors:  K F Becker; M J Atkinson; U Reich; I Becker; H Nekarda; J R Siewert; H Höfler
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

5.  Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.

Authors:  H Ohtani; Z Jin; S Takegawa; T Nakayama; O Yoshie
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

6.  Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.

Authors:  R J Kalish; P E Clancy; M B Orringer; H D Appelman
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

Review 7.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

Review 8.  HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Authors:  C Gravalos; A Jimeno
Journal:  Ann Oncol       Date:  2008-04-25       Impact factor: 32.976

9.  Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.

Authors:  J Henrik Simán; Lars Engstrand; Göran Berglund; Arne Forsgren; Claes-Henrik Florén
Journal:  Scand J Gastroenterol       Date:  2007-08       Impact factor: 2.423

Review 10.  Pathology of upper gastrointestinal malignancies.

Authors:  Mario Sarbia; Karl Friedrich Becker; Heinz Höfler
Journal:  Semin Oncol       Date:  2004-08       Impact factor: 4.929

View more
  10 in total

Review 1.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study.

Authors:  Fatma M Shebl; Ann W Hsing; Yikyung Park; Albert R Hollenbeck; Lisa W Chu; Tamra E Meyer; Jill Koshiol
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

Review 3.  Epstein-Barr virus infection and gastric cancer: a systematic review.

Authors:  Xin-Zu Chen; Hongda Chen; Felipe A Castro; Jian-Kun Hu; Hermann Brenner
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity.

Authors:  Rebecca Posselt; Katharina Erlenbach-Wünsch; Matthias Haas; Jonas Jeßberger; Maike Büttner-Herold; Marlen Haderlein; Markus Hecht; Arndt Hartmann; Rainer Fietkau; Luitpold V Distel
Journal:  Oncotarget       Date:  2016-09-13

Review 5.  Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.

Authors:  Jung Soo Lee; Hye Sung Won; Der Sheng Sun; Ji Hyung Hong; Yoon Ho Ko
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

Review 6.  The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Authors:  Geok Wee Tan; Lydia Visser; Lu Ping Tan; Anke van den Berg; Arjan Diepstra
Journal:  Pathogens       Date:  2018-04-13

7.  MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinoma.

Authors:  Xiaojie Chen; Shegan Gao; Zhiwei Zhao; Gaofeng Liang; Jinyu Kong; Xiaoshan Feng
Journal:  Cell Biosci       Date:  2020-06-16       Impact factor: 7.133

8.  Radioprotective properties of tocopherol succinate against ionizing radiation in mice.

Authors:  Vijay K Singh; Pankaj K Singh; Stephen Y Wise; Ana Posarac; Oluseyi O Fatanmi
Journal:  J Radiat Res       Date:  2012-10-03       Impact factor: 2.724

9.  Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma.

Authors:  Na-na Zhang; Jian-ning Chen; Lin Xiao; Fang Tang; Zhi-gang Zhang; Yi-wang Zhang; Zhi-ying Feng; Ye Jiang; Chun-kui Shao
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

10.  Regulatory T-cell density and cytotoxic T lymphocyte density are associated with complete response to neoadjuvant paclitaxel and carboplatin chemoradiotherapy in gastric cancer.

Authors:  Di Huang; Yongjiang Yang; Shuai Zhang; Zhuobin Su; Tao Peng; Xiaoyuan Wang; Yifeng Zhao; Shuguang Li
Journal:  Exp Ther Med       Date:  2018-09-03       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.